1. Axelsson R, Martensson E (1983) Clinical effects related to the serum concentrations of thioridazine and its metabolites. In: Gram LF, Usdin E, Dahl SG, Kragh-Sorensen P, Sjöqvist F, Morselli PL (eds) Clinical pharmacology in psychiatry. Macmillan, London, pp 165–174
2. Babiker IE (1986) Noncompliance in schizophrenia. Psychiatr Dev 4: 329–337
3. Balant-Gorgia AE, Eisele R, BalantL, Garrone G (1984) Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia. Eur Arch Psychiatr Neurol Sci 234: 1–4
4. Baldessarini R] (1985) Chemotherapy in psychiatry: principles and practice. Harvard University Press, Cambridge
5. Bareggi SR, Mauri M, Cavallaro R, Regazzetti MG, Moro AR (1990) Factors affecting the clinical response to haloperidol therapy in schizophrenia. Clin Neuropharmacol 13 [Suppl 1]: S29–S34